Running Oak Capital LLC Cuts Stock Holdings in Maximus, Inc. (NYSE:MMS)

Running Oak Capital LLC decreased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 61.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,762 shares of the health services provider’s stock after selling 56,119 shares during the period. Running Oak Capital LLC owned 0.06% of Maximus worth $2,999,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Verdence Capital Advisors LLC grew its holdings in shares of Maximus by 3.2% during the fourth quarter. Verdence Capital Advisors LLC now owns 4,563 shares of the health services provider’s stock valued at $383,000 after buying an additional 140 shares during the last quarter. VisionPoint Advisory Group LLC raised its position in Maximus by 61.4% in the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock worth $28,000 after acquiring an additional 145 shares during the period. Retirement Systems of Alabama raised its position in shares of Maximus by 0.3% during the 4th quarter. Retirement Systems of Alabama now owns 76,128 shares of the health services provider’s stock valued at $6,384,000 after purchasing an additional 232 shares during the period. Arizona State Retirement System raised its position in shares of Maximus by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 17,307 shares of the health services provider’s stock valued at $1,292,000 after purchasing an additional 237 shares during the period. Finally, Synovus Financial Corp increased its holdings in Maximus by 3.9% in the 3rd quarter. Synovus Financial Corp now owns 8,085 shares of the health services provider’s stock valued at $604,000 after acquiring an additional 307 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Trading Up 1.3 %

MMS stock traded up $1.06 during mid-day trading on Thursday, reaching $81.80. The company had a trading volume of 173,676 shares, compared to its average volume of 325,002. The firm has a 50 day moving average of $82.36 and a 200 day moving average of $81.43. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $89.69. The company has a market capitalization of $4.99 billion, a PE ratio of 26.75 and a beta of 0.72. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.06. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. Maximus’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.94 earnings per share. On average, equities analysts predict that Maximus, Inc. will post 5.42 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be paid a $0.30 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.47%. Maximus’s payout ratio is currently 39.74%.

Insider Activity at Maximus

In other Maximus news, CFO David Mutryn sold 8,000 shares of the stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at $430,159.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.40% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MMS shares. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 8th. Raymond James cut shares of Maximus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 3rd.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.